- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.90 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)
- 2 x HFG: 7-bromo-6-chloro-3-{3-[(2R,3S)-3-hydroxypiperidin-2-yl]-2-oxopropyl}quinazolin-4(3H)-one(Non-covalent)
HFG.2: 17 residues within 4Å:- Chain A: F.95, E.98, V.99, P.118, T.119, E.121, R.150, W.167, E.169, H.171, F.214, T.238, H.240, S.268, W.269, G.270
- Ligands: ANP.1
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:P.118, A:F.214
- Hydrogen bonds: A:R.150, A:S.268
- pi-Stacking: A:F.95, A:F.95
HFG.21: 17 residues within 4Å:- Chain B: F.95, E.98, V.99, P.118, T.119, E.121, R.150, W.167, E.169, H.171, F.214, T.238, H.240, S.268, W.269, G.270
- Ligands: ANP.20
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:P.118, B:F.214
- Hydrogen bonds: B:T.119, B:R.150, B:S.268
- pi-Stacking: B:F.95, B:F.95
- 30 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 3 residues within 4Å:- Chain A: N.21, F.22, S.23
Ligand excluded by PLIPSO4.4: 4 residues within 4Å:- Chain A: Y.38, S.42, G.43, Y.45
Ligand excluded by PLIPSO4.5: 3 residues within 4Å:- Chain A: E.72
- Chain B: Y.298, R.353
Ligand excluded by PLIPSO4.6: 4 residues within 4Å:- Chain A: G.94, F.95, S.96, P.97
Ligand excluded by PLIPSO4.7: 4 residues within 4Å:- Chain A: R.338, A.339, S.340
- Chain B: R.136
Ligand excluded by PLIPSO4.8: 4 residues within 4Å:- Chain A: E.34, H.349, W.350, R.353
Ligand excluded by PLIPSO4.9: 6 residues within 4Å:- Chain A: K.18, E.229, T.282, H.283, G.284, K.411
Ligand excluded by PLIPSO4.10: 3 residues within 4Å:- Chain A: S.42, W.151, R.163
Ligand excluded by PLIPSO4.11: 3 residues within 4Å:- Chain A: Y.53, E.56, C.57
Ligand excluded by PLIPSO4.12: 3 residues within 4Å:- Chain A: Y.53, K.297, N.332
Ligand excluded by PLIPSO4.13: 8 residues within 4Å:- Chain A: Y.52, E.56, Q.59
- Chain B: Q.59, N.63, N.73, W.145
- Ligands: SO4.32
Ligand excluded by PLIPSO4.14: 7 residues within 4Å:- Chain A: N.63, I.66, K.67, V.71, E.72, N.73
- Chain B: E.56
Ligand excluded by PLIPSO4.15: 6 residues within 4Å:- Chain A: E.177, N.218, Y.241, G.243, T.244, H.265
Ligand excluded by PLIPSO4.16: 4 residues within 4Å:- Chain A: N.378, E.380, N.403, K.407
Ligand excluded by PLIPSO4.17: 1 residues within 4Å:- Chain A: R.455
Ligand excluded by PLIPSO4.22: 3 residues within 4Å:- Chain B: N.21, F.22, S.23
Ligand excluded by PLIPSO4.23: 4 residues within 4Å:- Chain B: Y.38, S.42, G.43, Y.45
Ligand excluded by PLIPSO4.24: 3 residues within 4Å:- Chain A: Y.298, R.353
- Chain B: E.72
Ligand excluded by PLIPSO4.25: 4 residues within 4Å:- Chain B: G.94, F.95, S.96, P.97
Ligand excluded by PLIPSO4.26: 4 residues within 4Å:- Chain A: R.136
- Chain B: R.338, A.339, S.340
Ligand excluded by PLIPSO4.27: 4 residues within 4Å:- Chain B: E.34, H.349, W.350, R.353
Ligand excluded by PLIPSO4.28: 6 residues within 4Å:- Chain B: K.18, E.229, T.282, H.283, G.284, K.411
Ligand excluded by PLIPSO4.29: 3 residues within 4Å:- Chain B: S.42, W.151, R.163
Ligand excluded by PLIPSO4.30: 3 residues within 4Å:- Chain B: Y.53, E.56, C.57
Ligand excluded by PLIPSO4.31: 3 residues within 4Å:- Chain B: Y.53, K.297, N.332
Ligand excluded by PLIPSO4.32: 8 residues within 4Å:- Chain A: Q.59, N.63, N.73, W.145
- Chain B: Y.52, E.56, Q.59
- Ligands: SO4.13
Ligand excluded by PLIPSO4.33: 7 residues within 4Å:- Chain A: E.56
- Chain B: N.63, I.66, K.67, V.71, E.72, N.73
Ligand excluded by PLIPSO4.34: 6 residues within 4Å:- Chain B: E.177, N.218, Y.241, G.243, T.244, H.265
Ligand excluded by PLIPSO4.35: 4 residues within 4Å:- Chain B: N.378, E.380, N.403, K.407
Ligand excluded by PLIPSO4.36: 1 residues within 4Å:- Chain B: R.455
Ligand excluded by PLIP- 2 x NA: SODIUM ION(Non-functional Binders)
NA.18: 5 residues within 4Å:- Chain A: Q.235, R.274, S.505, Y.506
- Ligands: ANP.1
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:Q.235, A:R.274, A:Y.506
NA.37: 5 residues within 4Å:- Chain B: Q.235, R.274, S.505, Y.506
- Ligands: ANP.20
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:Q.235, B:R.274, B:S.505
- 2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.19: 5 residues within 4Å:- Chain A: E.34, E.37, R.48
- Chain B: K.130, W.131
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:E.34, A:E.37, A:R.48, A:R.48
EDO.38: 5 residues within 4Å:- Chain A: K.130, W.131
- Chain B: E.34, E.37, R.48
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:E.34, B:E.37, B:R.48, B:R.48
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dranow, D.M. et al., Crystal Structure of Prolyl-tRNA synthetase (ProRS, Proline--tRNA ligase)from Plasmodium falciparum in complex with Halofuginone and AMPPNP. To be Published
- Release Date
- 2015-04-15
- Peptides
- Proline--tRNA ligase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.90 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)
- 2 x HFG: 7-bromo-6-chloro-3-{3-[(2R,3S)-3-hydroxypiperidin-2-yl]-2-oxopropyl}quinazolin-4(3H)-one(Non-covalent)
- 30 x SO4: SULFATE ION(Non-functional Binders)
- 2 x NA: SODIUM ION(Non-functional Binders)
- 2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dranow, D.M. et al., Crystal Structure of Prolyl-tRNA synthetase (ProRS, Proline--tRNA ligase)from Plasmodium falciparum in complex with Halofuginone and AMPPNP. To be Published
- Release Date
- 2015-04-15
- Peptides
- Proline--tRNA ligase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A